drugset
drugset / Trial / NCT06262594

Lemborexant Treatment of Insomnia Linked to Epilepsy

NCT06262594 ↗

Phase 3 Recruiting 26 enrolled University of Manitoba Duke University · collab
RandomizedCrossoverTriple-blindTreatment

Summary

The goal of this clinical trial is to assess whether Lemborexant can improve sleep in patients with epilepsy.

Timeline

Start
2024-10-29
Primary completion
2026-04-18
Completion
2027-04-18

Drugs

EvaluationDrugModalityDoseRoute
Comparator Lemborexant Small molecule 10 mg —

Indications

epilepsy